Drugs and biologicals
Ended Awarded
- Contract number
- HHSN26300257
- Awardee
-
Lonza Walkersville, Inc. UEI LEEXJC9L4NF5
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,254
Award facts
- Contract value 100% obligated
- $5,254.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Walkersville, MD 21793, USA
Award details come from SAM.gov/FPDS.
About this award
This contract award represents a Blanket Purchase Agreement (BPA) call issued by the Office of the Director, a civilian agency under the Department of Health and Human Services. Lonza Walkersville, Inc., a foreign-owned biological materials and laboratory equipment manufacturer based in Walkersville, Maryland, was awarded a firm fixed-price contract with a ceiling value of $5,254.44 for drugs and biologicals. The award was issued on June 15, 2012, with an ultimate completion date of December 31, 2012. No set-aside designation was applied to this procurement, indicating open competition. This call order was placed against Lonza Walkersville's larger single-award BPA valued at $10 million and valid through December 31, 2025, which enables streamlined acquisition of biological materials, blood products, media products, laboratory supplies, and associated scientific equipment.
Lonza Walkersville, Inc. has been a registered vendor in the System for Award Management (SAM) since 2002 and serves as a critical supplier of specialized research products to federal agencies, particularly the National Institutes of Health and its various institutes. The company specializes in providing high-precision biological research products including cell culture media, specialized cell lines, transfection devices, and advanced scientific instrumentation. Under the umbrella BPA, the company supports research initiatives across multiple NIH institutes and research centers, with individual task orders typically ranging from approximately $10,000 to $225,400, supporting critical research in cancer studies, infectious diseases, regenerative medicine, and cellular engineering.
Quick answers
Who was awarded contract HHSN26300257?
HHSN26300257 was awarded to Lonza Walkersville, Inc. by Office of the Director (National Institutes of Health) on June 15, 2012.
How much is contract HHSN26300257 worth?
The government has obligated $5,254 on HHSN26300257.
Is contract HHSN26300257 an order under another contract?
Yes. HHSN26300257 is a BPA call under HHSN263199900049886B, a blanket purchase agreement.
Was contract HHSN26300257 competed?
The extent of competition for HHSN26300257 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award